Add BrightSurf on Google Email

DNA repair system affects colon cancer recurrence and survival

Patients with mismatch repair defects have lower tumor recurrence rates, longer remissions, and improved overall and disease-free survival compared to those without the defects. The study suggests that these defects are associated with a reduced response to 5-FU therapy, particularly in patients with inherited defects.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 19, 2011

ASGE initiative examines real-time endoscopic assessment of the histology of diminutive colorectal polyps

The ASGE has established guidelines for the use of real-time endoscopic assessment in managing diminutive colorectal polyps. The recommendations aim to minimize risk and delay while improving cost effectiveness of colonoscopy. Diminutive polyps are common, but pathological assessment can be costly and delay patient information.

SourceAmerican Society for Gastrointestinal Endoscopy·JournalGastrointestinal Endoscopy·DateMar 8, 2011

Increased consumption of folic acid can reduce birth defects but blood levels in Canadians are now high

Researchers found less than 1% of Canadians had folate deficiencies, while 22% of women of childbearing age were below safe levels for preventing neural tube defects. The study suggests that high folic acid consumption may not be as effective in reducing birth defects as previously thought.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateDec 13, 2010

Surgery complications linked to chemotherapy delay, U-M study finds

A new study from the University of Michigan Comprehensive Cancer Center found that chemotherapy delays are common among patients with surgical complications after colorectal cancer surgery. The study, which analyzed data from 17,108 patients, suggests that surgical complications can have long-term impacts on quality of care.

SourceMichigan Medicine - University of Michigan·JournalDiseases of the Colon & Rectum·DateDec 8, 2010

Latinas: 'Cancer was just meant to be'

A new study shows that fatalistic thinking in Latinas may prevent them from using cancer screening services. Seven out of eleven studies found a statistically significant inverse association between fatalism and utilization of cancer screening services.

SourceSpringer·JournalInternational Journal of Behavioral Medicine·DateOct 18, 2010

Not all doctors follow cancer screening guidelines

A new study found that only one-fifth of primary care physicians follow practice guidelines for all recommended colorectal cancer screening tests. Many clinicians overuse or underuse screening, leading to unnecessary testing and potential complications.

SourceSpringer·JournalJournal of General Internal Medicine·DateOct 14, 2010

Cetuximab did not add significant benefit to NORDIC FLOX regimen in first line treatment of mCRC

Researchers reported that adding cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer did not improve response rates, progression-free survival, or overall survival. The NORDIC VII study included 566 patients and found no statistically significant differences between the treatment groups.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateOct 10, 2010